195 related articles for article (PubMed ID: 16207590)
1. Immune pathophysiology of aplastic anemia.
Nakao S; Feng X; Sugimori C
Int J Hematol; 2005 Oct; 82(3):196-200. PubMed ID: 16207590
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies frequently detected in patients with aplastic anemia.
Hirano N; Butler MO; Von Bergwelt-Baildon MS; Maecker B; Schultze JL; O'Connor KC; Schur PH; Kojima S; Guinan EC; Nadler LM
Blood; 2003 Dec; 102(13):4567-75. PubMed ID: 12947009
[TBL] [Abstract][Full Text] [Related]
3. [Immune pathophysiology of acquired aplastic anemia].
Ishiyama K
Rinsho Ketsueki; 2016 May; 57(5):525-30. PubMed ID: 27263775
[TBL] [Abstract][Full Text] [Related]
4. Immune pathophysiology of aplastic anemia.
Maciejewski JP; Risitano A; Kook H; Zeng W; Chen G; Young NS
Int J Hematol; 2002 Aug; 76 Suppl 1():207-14. PubMed ID: 12430855
[TBL] [Abstract][Full Text] [Related]
5. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
[TBL] [Abstract][Full Text] [Related]
6. Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic?
Nissen C; Schubert J
Hematol J; 2002; 3(4):169-75. PubMed ID: 12189561
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic aplastic anemia: diagnosis and classification.
Dolberg OJ; Levy Y
Autoimmun Rev; 2014; 13(4-5):569-73. PubMed ID: 24424170
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.
Young NS
Semin Hematol; 2000 Jan; 37(1):3-14. PubMed ID: 10676907
[No Abstract] [Full Text] [Related]
9. Identification of autoantibodies expressed in acquired aplastic anaemia.
Goto M; Kuribayashi K; Takahashi Y; Kondoh T; Tanaka M; Kobayashi D; Watanabe N
Br J Haematol; 2013 Feb; 160(3):359-62. PubMed ID: 23116149
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
[TBL] [Abstract][Full Text] [Related]
11. "Myelophrenia": its contribution to the management of aplastic anemia.
Nathan DG
Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
[No Abstract] [Full Text] [Related]
12. Treatment of aplastic anemia.
Gordon-Smith EC
Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
[No Abstract] [Full Text] [Related]
13. [Physiopathology of and therapy for aplastic anemia].
Nakao S
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1851-7. PubMed ID: 17037326
[No Abstract] [Full Text] [Related]
14. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
Dubey S; Shukla P; Nityanand S
Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
[TBL] [Abstract][Full Text] [Related]
15. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells.
Knospe WH; Husseini SG; Chiu KM; Fried W
Exp Hematol; 1994 Jul; 22(7):573-81. PubMed ID: 8013573
[TBL] [Abstract][Full Text] [Related]
16. Delayed activation-induced T lymphocytes death in aplastic anemia: related with abnormal Fas system.
Kim SC; Min YH; Lee S; Chung SY; Yoo NC; Lee JW; Hahn JS; Ko YW
Korean J Intern Med; 1998 Feb; 13(1):41-6. PubMed ID: 9538630
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of osteonectin and increased natural killer cells may contribute to the pathophysiology of aplastic anemia.
Park M; Park CJ; Jang S; Kim DY; Lee JH; Lee JH; Lee KH; Hwang K; Lee YH
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):139-45. PubMed ID: 25032754
[TBL] [Abstract][Full Text] [Related]
18. Aplastic anemia successfully treated with rituximab: the possible role of aplastic anemia-associated autoantibodies as a marker for response.
Takamatsu H; Yagasaki H; Takahashi Y; Hama A; Saikawa Y; Yachie A; Koizumi S; Kojima S; Nakao S
Eur J Haematol; 2011 Jun; 86(6):541-5. PubMed ID: 21418330
[TBL] [Abstract][Full Text] [Related]
19. [Immune pathophysiology of refractory anemias].
Nakao S
Nihon Rinsho; 2008 Mar; 66(3):453-9. PubMed ID: 18326316
[TBL] [Abstract][Full Text] [Related]
20. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
Piao W; Grosse J; Czwalinna A; Ivanyi P; Ganser A; Franzke A
Exp Hematol; 2005 Jul; 33(7):804-10. PubMed ID: 15963856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
